Founded
23 Jun 1997
Address
Bay City Capital LLC
750 Battery Street
Suite 400
San Francisco, CA 94111
United States
Phone
Website
Industry
VCID: 2637
Profile
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Nevro Corp Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. |
United States | 1 Aug 2008 1 Jul 2011 |
N/A |
|
|
|
Calypso Medical Technologies Inc A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. |
United States | 2 Nov 2009 7 Jan 2005 |
Series E Round participant. Active |
|
|
|
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Apr 2007 1 Nov 2009 |
N/A |
|
|
|
Presidio Pharmaceuticals Inc Drug discovery and development, focused on anti-viral indications |
United States | 1 Aug 2007 1 Jul 2009 |
N/A |
|
|
|
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | N/A |
||
|
|
IDEV Technologies Inc Developer of next generation medical devices for use in the interventional radiology, vascular surgery, and cardiology device marketplace. |
United States | N/A |
||
|
|
Amerifit Nutrition Inc Develops, sources, markets, and sells branded nutritional supplement products, targeting select consumer growth segments. |
United States | N/A |
||
|
|
Ion Torrent Systems Inc ION Torrent Systems pioneered an entirely new approach to sequencing that enables a direct connection between chemical and digital information. |
United States | N/A Initial investment. Round participant. Exited (Trade sale) |
||
|
|
Pharmanex LLC Create safe and efficient dietary supplements by applying the disciplines of Western science to natural products. |
United States | N/A Active |
||
|
|
Syrrx Inc Combines high-throughput structure determination, HTS, combinatorial and medicinal chemistry together with computational methods to discover novel sma |
United States | N/A |
||
|
|
VIA Pharmaceuticals Inc Drug development company targeting vascular inflammation. |
United States | N/A |
||
|
|
Cadence Pharmaceuticals Inc Focused on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting. |
United States | N/A |
||
|
Intarcia Therapeutics Inc A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t |
United States | N/A |
||
|
|
Poniard Pharmaceuticals Inc Develops and commercializes oncology products. |
United States | N/A |
||
|
|
Aquabounty Technologies Inc Develops innovative technologies to significantly improve the economics and productivity of fish farming. |
United States | N/A |
||
|
|
Lexicon Pharmaceuticals Inc Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. |
United States | N/A |